Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1984-02-24
1987-09-08
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
530387, A61K 39395
Patent
active
046923314
ABSTRACT:
A dry .gamma.-globulin preparation capable of intravenous injection which is obtainable by polyethylene glycol fractionation of plasma is improved in its water-solubility and stability against increase of anticomplement activity and decrease of antibody titer by purifying the .gamma.-globulin fraction with respect to protein to render the residual polyethylene glycol substantially not detectable in its 5% W/V solution, adding 0.2 to 2 parts by weight of glucose based on 1 part of .gamma.-globulin, and lyophilizing its solution.
REFERENCES:
patent: 4124576 (1978-07-01), Coval
patent: 4165370 (1979-08-01), Coval
patent: 4362661 (1982-12-01), Ono et al.
patent: 4374763 (1983-02-01), Takage
patent: 4482483 (1984-11-01), Curry et al.
Rahn, Physical Method of Sterilization of Microorganisms, Bact. Rev., 9, pp. 1 and 24, 1945.
Deiwest Abstract of Japanese Laid Open Patent Application No. 3047-515, 1978.
Funakoshi Satoshi
Uemura Yahiro
Hazel Blondel
The Green Cross Corporation
LandOfFree
Gamma-globulin preparation for intravenous administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-globulin preparation for intravenous administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-globulin preparation for intravenous administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157496